glp-1 boosters From Medicine to Revolution: How is Transforming Food & Consumption » PeakBridge VC Bundle:2 months supply Collection_clearance The expanding scope of

glp-1 boosters From Medicine to Revolution: How is Transforming Food & Consumption » PeakBridge VC Bundle:2 months supply Collection_clearance The expanding scope of

The expanding scope of GLP-1 receptor agonists: Six uses beyond diabetes - PMC

Sample Size: 125,474 adults T2DM (61.0% of total sample, n = 76,524) 98.6% (n = 75,434) using GLP-1s as antidiabetic medications 1.4% (n = 1,090) using GLP-1s as antiobesity medications Without T2DM (39.0% of total sample, n = 48,950) 61.8% (n = 30,236) using GLP-1s off-label as antidiabetic medications 38.2% (n = 18,714) using GLP-1s specifically for weight management Data Source: Truveta Data – Aggregated electronic health record (EHR) data from 30 U.S

Collection_clearance

Bundle:2 months supply

Approval ultimately came nearly two months after the initial request